{"nct_id":"NCT04072952","title":"A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-08-05","start_date_type":"ACTUAL","primary_completion_date":"2024-09-13","primary_completion_date_type":"ACTUAL","completion_date":"2025-11-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ARVN"]}